Ghiglieri, Veronica
 Distribuzione geografica
Continente #
NA - Nord America 1.351
EU - Europa 1.150
AS - Asia 492
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
AF - Africa 1
Totale 3.001
Nazione #
US - Stati Uniti d'America 1.347
IE - Irlanda 273
IT - Italia 211
SG - Singapore 190
FR - Francia 172
UA - Ucraina 169
VN - Vietnam 98
HK - Hong Kong 84
SE - Svezia 74
FI - Finlandia 66
CN - Cina 59
RU - Federazione Russa 56
KR - Corea 47
DE - Germania 45
GB - Regno Unito 27
RO - Romania 22
TR - Turchia 9
NL - Olanda 8
CH - Svizzera 5
CZ - Repubblica Ceca 5
EU - Europa 5
AT - Austria 4
BE - Belgio 4
GR - Grecia 4
MX - Messico 3
PL - Polonia 2
TW - Taiwan 2
BR - Brasile 1
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
ES - Italia 1
IR - Iran 1
LB - Libano 1
NO - Norvegia 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 3.001
Città #
Dublin 273
Chandler 231
San Mateo 144
Singapore 141
Boardman 109
Dong Ket 98
Jacksonville 92
Altamura 84
Hong Kong 84
Santa Clara 77
Medford 69
Princeton 69
Perugia 68
Lawrence 67
Ann Arbor 64
Andover 54
Seoul 47
Wilmington 44
Beijing 33
Bucharest 21
Saint Petersburg 19
Des Moines 18
Norwalk 18
Helsinki 12
Rome 10
San Paolo di Civitate 10
Izmir 9
Woodbridge 9
Redwood City 8
Ashburn 7
Munich 7
Redmond 7
Den Haag 6
Falls Church 6
Moscow 6
Brno 4
Brussels 4
Dearborn 4
Los Angeles 4
Terni 4
Dallas 3
Bolzano 2
Chicago 2
Hackney 2
Miaoli 2
Utrecht 2
Abidjan 1
Aprilia 1
Bettona 1
Changsha 1
Derio 1
Espoo 1
Florence 1
Frankfurt Am Main 1
Fremont 1
Fuzhou 1
Glencoe 1
Lausanne 1
Machado 1
Mexico City 1
Monterrey 1
Pars 1
Piacenza 1
Reston 1
Shanghai 1
Sovicille 1
Suceava 1
Xi'an 1
Totale 2.076
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 151
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 110
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 84
Attachment and parental reflective functioning features in ADHD: Enhancing the knowledge on parenting characteristics 69
Functional interactions within striatal microcircuit in animal models of Huntington's disease. 66
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease. 62
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia. 62
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. 61
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 60
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 60
Le emozioni nei contesti individuali e sociali 58
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 58
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 57
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 56
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 56
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 55
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 55
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 54
DIRECT AND INDIRECT PATHWAYS IN LEVODOPA-INDUCED DYSKINESIA: A MORE COMPLEX MATTER THAN A NETWORK IMBALANCE. 53
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 52
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 51
l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors. 51
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 50
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease 50
Theta-burst stimulation and striatal plasticity in experimental parkinsonism. 49
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 49
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 48
Direct and indirect pathways of basal ganglia: a critical reappraisal. 47
Alpha-synuclein: From early synaptic dysfunction to neurodegeneration 47
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 43
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. 42
Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia 41
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 41
The endocannabinoid system in Parkinson's disease. 40
Prenatal stress and hippocampal BDNF expression: a fading imperative. 40
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 39
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 39
Cigarette smoke inhalation stimulates dopaminergic neurons in rats 39
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 39
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 38
L-3,4-dihydroxyphenylalanine-inducedsprouting of serotonin axon terminals: A useful biomarker for dyskinesias? 38
"Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease. 36
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid. 36
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 36
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 35
Synaptic dysfunction in Parkinson's disease. 34
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 34
Plastic abnormalities in experimental Huntington's disease. 34
Molecular mechanisms underlying levodopa-induced dyskinesia. 34
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology 33
Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease. 32
Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels 31
Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity 31
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 31
Striatum-hippocampusbalance: from physiological behavior to interneuronal pathology. 31
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 30
Environmental enrichment repairs structural and functional plasticity in the hippocampus 30
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat 30
Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure. 29
Interaction between basal ganglia and limbic circuits in learning and memory processes 29
Hyperkinetic disorders and loss of synaptic downscaling 29
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 29
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release 29
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. 28
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 28
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats 28
Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury 28
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 27
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 27
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP. 25
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction 11
Hippocampal neuroplasticity and inflammation: Relevance for multiple sclerosis 8
Totale 3.173
Categoria #
all - tutte 14.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 0 0 42 24 30 28 29 31 7 13
2020/2021461 4 23 11 26 157 18 31 3 39 13 31 105
2021/2022565 9 102 18 17 14 5 10 184 10 27 73 96
2022/2023897 76 215 8 55 65 82 0 32 334 1 21 8
2023/2024309 20 30 19 8 0 1 57 2 28 8 66 70
2024/2025337 50 78 31 26 152 0 0 0 0 0 0 0
Totale 3.173